» Authors » Tobias Akerstrom

Tobias Akerstrom

Explore the profile of Tobias Akerstrom including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 361
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Berntson L, von Seth M, Bulow Anderberg S, Akerstrom T, Kurland S
Lakartidningen . 2021 May; 118. PMID: 33999400
Multisystem inflammatory syndrome in adults, MIS-A, is a rare but severe post-covid-19 immunologic complication. The presentation is similar to Multisystem inflammatory syndrome in children, MIS-C. Both MIS-A/C are life-threatening immunologic...
12.
Jiang J, Zhang J, Pang Y, Bechmann N, Li M, Monteagudo M, et al.
J Clin Endocrinol Metab . 2020 Aug; 105(10). PMID: 32750708
Context: Pheochromocytomas and paragangliomas (PPGLs) are characterized by distinct genotype-phenotype relationships according to studies largely restricted to Caucasian populations. Objective: To assess for possible differences in genetic landscapes and genotype-phenotype...
13.
Backman S, Akerstrom T, Maharjan R, Cupisti K, Willenberg H, Hellman P, et al.
Sci Rep . 2019 Apr; 9(1):6269. PMID: 31000732
Aldosterone producing adenomas (APAs) occur in the adrenal glands of around 30% of patients with primary aldosteronism, the most common form of secondary hypertension. Somatic mutations in KCNJ5, ATP1A1, ATP2B3,...
14.
Hellman P, Bjorklund P, Akerstrom T
Vitam Horm . 2019 Jan; 109:407-431. PMID: 30678866
Aldosterone-producing adenomas (APA) are more common than initially anticipated. APA cause primary aldosteronism (PA), which affect 3-10% of the hypertensive population. Research during recent years has led to an increased...
15.
Maharjan R, Backman S, Akerstrom T, Hellman P, Bjorklund P
Sci Rep . 2018 Jun; 8(1):8610. PMID: 29872083
The Wnt/β-Catenin signaling pathway is one of the most frequently altered pathways in adrenocortical carcinomas (ACCs). The aim of this study was to investigate the status of Wnt/β-Catenin signaling pathway...
16.
Akerstrom T, Maharjan R, Willenberg H, Cupisti K, Ip J, Moser A, et al.
Sci Rep . 2016 Jan; 6:19546. PMID: 26815163
Primary aldosteronism (PA) is the most common cause of secondary hypertension with a prevalence of 5-10% in unreferred hypertensive patients. Aldosterone producing adenomas (APAs) constitute a large proportion of PA...
17.
Akerstrom T, Willenberg H, Cupisti K, Ip J, Backman S, Moser A, et al.
Endocr Relat Cancer . 2015 Aug; 22(5):735-44. PMID: 26285814
Aldosterone-producing adenomas (APAs) are found in 1.5-3.0% of hypertensive patients in primary care and can be cured by surgery. Elucidation of genetic events may improve our understanding of these tumors...
18.
Crona J, Gustavsson T, Norlen O, Edfeldt K, Akerstrom T, Westin G, et al.
Ann Surg Oncol . 2015 Jan; 22 Suppl 3:S1428-35. PMID: 25586243
Background: Until recently, the genetic landscape of small intestinal neuroendocrine tumors (SI-NETs) was limited to recurrent copy number alterations, most commonly a loss on chromosome 18. Intertumor heterogeneity with nonconcordant...
19.
Akerstrom T, Crona J, Verdugo A, Starker L, Cupisti K, Willenberg H, et al.
PLoS One . 2012 Aug; 7(7):e41926. PMID: 22848660
Background: Aldosterone producing lesions are a common cause of hypertension, but genetic alterations for tumorigenesis have been unclear. Recently, either of two recurrent somatic missense mutations (G151R or L168R) was...
20.
Staaf J, Akerstrom T, Ljungstrom V, Larsson S, Karlsson T, Skogseid B, et al.
Lakartidningen . 2012 May; 109(17-18):898. PMID: 22642061
No abstract available.